Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.3336
-0.0156 (-4.47%)
At close: Nov 16, 2026, 4:00 PM EST
0.3330
-0.0006 (-0.18%)
After-hours: Nov 16, 2026, 7:57 PM EST
Tenaya Therapeutics Stock Forecast
TNYA's stock price has decreased by -74.92% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, Tenaya Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.67. The average 1-year stock price forecast is 999.22% higher than the current stock price, while the lowest is $2.00 (+499.52%) and the highest is $6.00 (+1,698.56%).
Price Target: $3.67 (+999.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tenaya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5 | Buy | Maintains | $5 | +1,398.80% | Nov 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $40 → $6 | Buy | Reiterates | $40 → $6 | +1,698.56% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $3 | Buy | Maintains | $3 | +799.28% | Nov 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $4 | Buy | Maintains | $4 | +1,099.04% | Aug 6, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 6, 2026 |
Financial Forecast
Revenue This Year
4.77M
Revenue Next Year
1.47M
from 4.77M
Decreased by -69.28%
EPS This Year
-0.44
from -0.59
EPS Next Year
-0.38
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.